CIK: 1628098 - Address: 300 Technology Square, 8Th Floor, Cambridge, MA 02139
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/13/24 19:53
3/11/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAtlas Venture Fund X, L.P.MATS.m-14,91242.200-353-65,505M
1/25/24 16:31
1/23/24
IRONDisc Medicine, Inc.DEHealthDrugPharmaceutical PreparationsAtlas Venture Fund X, L.P.MATS-10,14867.650-150-91,601M
1/12/24 17:12
1/10/24
IRONDisc Medicine, Inc.DEHealthDrugPharmaceutical PreparationsAtlas Venture Fund X, L.P.MATS-3,20064.000-50-22,236M
12/14/23 20:13
12/12/23
IRONDisc Medicine, Inc.DEHealthDrugPharmaceutical PreparationsAtlas Venture Fund X, L.P.MATS.m-11,68561.450-190-82,286M
9/18/23 16:59
9/14/23
IRONDisc Medicine, Inc.DEHealthDrugPharmaceutical PreparationsAtlas Venture Fund X, L.P.MATS.m-18,99253.130-357-181,594D
8/16/23 18:55
8/14/23
IRONDisc Medicine, Inc.DEHealthDrugPharmaceutical PreparationsAtlas Venture Fund X, L.P.MATS.m-18,84552.490-359-112,833M
1/13/23 16:50
1/11/23
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAtlas Venture Fund X, L.P.MATS.m-3,82230.220-126-25,858M
12/16/22 17:03
12/14/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAtlas Venture Fund X, L.P.MATS.m-11,98631.360-382-65,985M
11/4/22 16:30
11/2/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAtlas Venture Fund X, L.P.MATS.m-6,60330.010-220-36,367M
11/1/22 19:34
10/28/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAtlas Venture Fund X, L.P.MATS.m-8,73530.260-289-46,587M
3/22/19 17:03
3/20/19
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAtlas Venture Fund X, L.P.MATS-25417.860-1404,117M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact